Search
for

    Sort by

    Research

    60-90 / 1000+ results
      Drug-Induced Skin, Nail, and Hair Disorders

      research Drug-Induced Skin, Nail and Hair Disorders

      114 citations , January 2007 in “Drug Safety”
      This review discusses various adverse drug reactions affecting the skin, hair, and nails, emphasizing the importance of recognizing and reporting these reactions but reports no new clinical findings.
      Adverse Cutaneous Reactions to Mood Stabilizers

      research Adverse Cutaneous Reactions to Mood Stabilizers

      47 citations , January 2003 in “American Journal of Clinical Dermatology”
      This article discusses the potential for severe adverse cutaneous drug reactions with mood-stabilizing agents, emphasizing the importance of monitoring and patient communication, but reports no new clinical findings.
      Adverse Cutaneous Reactions to Antidepressants

      research Adverse Cutaneous Reactions to Antidepressants

      44 citations , January 2002 in “American Journal of Clinical Dermatology”
      This review discusses adverse cutaneous drug reactions associated with antidepressants and provides guidance on managing these reactions, but it reports no new clinical findings; the authors recommend cautious use and alternative treatment if reactions occur.
      Toxic Shock Syndrome: Recent Developments in Pathogenesis

      research Toxic shock syndrome: Recent developments in pathogenesis

      37 citations , March 1990 in “The Journal of Pediatrics”
      Toxic shock syndrome is caused by a complex interaction of bacterial toxins and the immune system, and understanding this can help improve diagnosis and treatment.
      Dermatologic Side Effects of Psychopharmacologic Agents

      research DERMATOLOGIC SIDE EFFECTS OF PSYCHOPHARMACOLOGIC AGENTS

      16 citations , July 1996 in “Dermatologic Clinics”
      This article discusses common dermatologic side effects of psychopharmacologic agents such as eruptions, urticaria, and photosensitivity, but it reports no new research findings.
      Nail Hyperpigmentation Following Valproic Acid Use: A Rare Case Report

      research Nail Hyperpigmentation Following Valproic Acid Use: A Rare Case Report

      February 2023 in “Indian journal of private psychiatry/Indian Journal of Private Psychiatry”
      This case report highlights a rare instance of fingernail and toenail hyperpigmentation following the use of valproic acid, which resolved after discontinuation of the drug.
      Systemic Antifungals: Overview, Applications, and Costs

      research Systemic Antifungals

      January 2018 in “Springer eBooks”
      Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.
      Index

      research Index

      November 2013
      This article provides a reference guide for various dermatological terms, treatments, and conditions, but reports no new clinical findings.
      Drug Eruptions in Dermatology

      research Drug eruptions in dermatology

      11 citations , June 2011 in “Expert Review of Dermatology”
      This review covers various skin-related adverse drug reactions and lists common drugs associated with these reactions but presents no new clinical findings.
      Late Presentation of Myotonic Dystrophy

      research Late presentation of myotonic dystrophy

      5 citations , January 1998 in “Clinical and experimental dermatology”
      This article discusses the late presentation of myotonic dystrophy but reports no new clinical findings.
      The Skin and Subcutaneous Tissues: Conditions, Diagnosis, and Systemic Implications

      research The Skin and Subcutaneous Tissues

      1 citations , January 2013 in “Springer eBooks”
      The document concludes that skin and nail changes can indicate various underlying health conditions.
      Drug Eruptions

      research Drug Eruptions

      November 2014
      This chapter discusses the mechanisms, presentation, course, differential diagnosis, and treatment of drug-induced skin reactions and reports no new clinical results.
      Cutaneous Complications of Chemotherapeutic Agents

      research Cutaneous complications of chemotherapeutic agents

      172 citations , November 1983 in “Journal of The American Academy of Dermatology”
      This article discusses the cutaneous side effects of various chemotherapeutic agents but reports no new clinical results; the authors emphasize the importance of dermatologists recognizing drug-induced skin reactions to better patient care.
      Generalized Pustular Psoriasis: A 29-Year Study of 63 Patients

      research Generalized Pustular Psoriasis

      143 citations , September 1991 in “Archives of Dermatology”
      In this study, patients with generalized pustular psoriasis were classified into subgroups to better understand the disease's variability and assist in treatment selection, highlighting the role of localized infections in triggering flares.
      Inherited Ichthyosis: Syndromic Forms

      research Inherited ichthyosis: Syndromic forms

      47 citations , March 2016 in “Journal of dermatology”
      This review discusses various rare syndromes associated with ichthyosis and emphasizes the importance of understanding their molecular genetics and mechanisms for developing effective treatments and genetic counseling, but it reports no new clinical findings.
      Drug-Induced Skin Reactions: A Pathologist's Viewpoint

      research Drug-induced skin reactions: a pathologist viewpoint

      7 citations , June 2015 in “Cutaneous and Ocular Toxicology”
      This study attempts to classify histomorphologic reactions to drugs to aid in diagnosing drug eruptions, which are common in hospitalized patients but lack specific diagnostic features.
      Adverse Cutaneous Effects of Psychotropic Medications

      research Adverse cutaneous effects of psychotropic medications

      6 citations , October 2013 in “Expert Review of Dermatology”
      This review explores how psychotropic medications can cause a range of skin reactions, from mild to life-threatening, and emphasizes the importance of monitoring for these adverse effects early in treatment.